ClinicalFDA Approved
Tetracosactide
Also known as: Cosyntropin · Synacthen
The synthetic ACTH(1-24) fragment used as the clinical gold standard to test adrenal cortisol-producing capacity (ACTH stimulation test).
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
Half-Life
~15 minutes
Typical Dose
250 mcg (diagnostic)
Administration
IM or IV injection
Mechanism of Action
Activates adrenal MC2R receptors to trigger maximum cortisol release, used diagnostically to identify adrenal insufficiency.
Key Research Areas
clinicaldiagnosticadrenalcortisol
Frequently Asked Questions
What is Tetracosactide?▾
The synthetic ACTH(1-24) fragment used as the clinical gold standard to test adrenal cortisol-producing capacity (ACTH stimulation test).
How does Tetracosactide work?▾
Activates adrenal MC2R receptors to trigger maximum cortisol release, used diagnostically to identify adrenal insufficiency.
What is the recommended dosage for Tetracosactide?▾
The typical research dosage is 250 mcg (diagnostic), administered via IM or IV injection. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Tetracosactide?▾
The half-life of Tetracosactide is approximately ~15 minutes. This affects dosing frequency and timing in research protocols.
Is Tetracosactide FDA approved?▾
Yes, Tetracosactide is FDA approved for specific medical indications. Consult your physician for proper medical guidance.
Research Disclaimer
The information provided about Tetracosactide is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.